Storage Condition
Refer MSDS for complete information
Synonyms
(S)-1-(4-Fluorophenyl)-1-(2-(4-(6-(1-(methyl-d3)-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazin-1-yl)pyrimidin-5-yl)ethan-1-amine
Application Notes
Useful research chemical for a range of applications
Hazard Compound
Refer MSDS for complete information
Avapritinib-d3 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Avapritinib-d3 usage and description
Avapritinib D3 is a deuterated form of Avapritinib, a small molecule inhibitor of the receptor tyrosine kinase KIT and platelet-derived growth factor receptor alpha (PDGFRA). It is used for the treatment of gastrointestinal stromal tumors (GISTs) that are unresectable, metastatic or have relapsed after surgery. GISTs are rare tumors that develop in the wall of the gastrointestinal tract, and Avapritinib D3 works by blocking the activity of the KIT and PDGFRA proteins, which are involved in the growth and survival of GISTs.
Chemically, Avapritinib D3 is a white to off-white crystalline powder with a molecular weight of 535.62 g/mol. It is highly soluble in water and has a melting point of around 200°C. The deuterated form of Avapritinib has been developed to improve the pharmacokinetic properties of the drug, which means that it is absorbed and distributed more efficiently in the body than the non-deuterated form. This can lead to a more effective and longer-lasting therapeutic effect, as well as reduced dosing frequency and side effects.
In summary, Avapritinib D3 is a potent and selective inhibitor of KIT and PDGFRA that is used for the treatment of GISTs. Its deuterated form improves its pharmacokinetic properties, which can enhance its efficacy and reduce side effects.
